Supplemental Table 6.
Baseline characteristics of arrhythmogenic right ventricular cardiomyopathy (ARVC) and control group, 1/3, 2/3, 3/3 novel criteria fulfilled necessary for diagnosis, respectively. All dogs included.
| Parameter | ARVC: 1 of 3 novel criteria | ARVC: 2 of 3 novel criteria | ARVC: 3 of 3 novel criteria | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ARVC (n = 89) |
Controls (n = 175) |
p-value | ARVC (n = 61) |
Controls (n = 203) |
p-value | ARVC (n = 36) |
Controls (n = 228) |
p-value | |
| Male Sex | 40 (44.9%) |
102 (58.3%) |
0.050 | 30 (49.2%) |
112 (55.2%) |
0.465 | 20 (55.6%) |
122 (53.5%) |
0.859 |
| Age | 6.55 ± 3.34 | 4.59 ± 3.16 | 0.000 | 7.21 ± 3.07 | 4.69 ± 3.22 | 0.000 | 7.29 ± 2.94 | 5.00 ± 3.32 | 0.000 |
| Echocardiogram | 88 (98.9%) |
173 (98.9%) |
1.000 | 60 (98.4%) |
201 (99.0%) |
0.547 | 35 (97.2%) |
226 (99.1%) |
0.357 |
| 24h-ECG | 89 (100%) |
42 (24.0%) |
0.000 | 61 (100%) |
70 (34.5%) |
0.000 | 36 (100%) |
95 (41.7%) |
0.000 |
| (Pre-) Syncope | 63 (79.7%) (n = 79) |
57 (42.5%) (n = 134) |
0.000 | 44 (80.0%) (n = 55) |
76 (48.1%) (n = 158) |
0.000 | 26 (78.8%) (n = 33) |
94 (52.2%) (n = 180) |
0.007 |
| (Pre-) Syncope at exertion | 31 (39.2%) |
23 (17.2%) |
0.001 | 19 (34.5%) |
35 (22.2%) |
0.075 | 11 (33.3%) |
43 (23.9%) |
0.278 |
| BNP | 2043 ± 1061 (n = 22) |
1356 ± 1112 (n = 18) |
0.054 | 2183 ± 925 (n = 16) |
1434 ± 1163 (n = 24) |
0.037 | 2339 ± 574 (n = 7) |
1606 ± 1176 (n = 33) |
0.118 |
| Troponin | 1.68 ± 3.89 (n = 33) |
0.38 ± 0.53 (n = 46) |
0.028 | 1.80 ± 4.21 (n = 26) |
0.49 ± 1.04 (n = 53) |
0.035 | 1.92 ± 3.85 (n = 13) |
0.73 ± 2.28 (n = 66) |
0.133 |
VPC: ventricular premature complexes; BNP: brain natriuretic peptide